Product Information

FT CHEST CONGEST 400 MG CAPLET is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.0681 per EA under NDC 70677105401. Its NADAC has been published 144 times since Sep 27, 2023.

FT CHEST CONGEST 400 MG CAPLET

Guaifenesin
$0.0681per EA
OTC

Strength

400 mg/1

NDC

70677105401

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

GUAIFENESIN

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

1/27/2023

Pharmacological Classes

Decreased Respiratory Secretion Viscosity
Expectorant
Increased Respiratory Secretions

Price Statistics

The NADAC for FT CHEST CONGEST 400 MG CAPLET has been published 144 times since Sep 27, 2023, and over the history we have for it it has declined 6.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0681 per EA
All-time high$0.0744 (Nov 13, 2024)
All-time low$0.0644 (Oct 18, 2023)
52-week high$0.0691
52-week low$0.0661
Median price$0.0682
Average price$0.0685
Largest weekly change-11.2% (Oct 18, 2023)
Weeks tracked144
Tracking sinceSep 27, 2023

Price History

1W

0.0%

1M

+1.3%

3M

+2.2%

6M

+1.9%

1Y

-1.5%

3Y

N/A

5Y

N/A

All

-6.2%

Generic Alternatives

The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of FT CHEST CONGEST 400 MG CAPLET?

The current National Average Drug Acquisition Cost (NADAC) for FT CHEST CONGEST 400 MG CAPLET, manufactured by Strategic Sourcing Services LLC, is $0.0681 per EA (NDC 70677105401), effective Jun 24, 2026.

How has the price of FT CHEST CONGEST 400 MG CAPLET changed over time?

Over the history we have for it, the NADAC for FT CHEST CONGEST 400 MG CAPLET has declined 6.2%. It has been tracked across 144 weekly CMS publications since Sep 27, 2023.

What are the highest and lowest recorded NADAC prices for FT CHEST CONGEST 400 MG CAPLET?

Since Sep 27, 2023, the NADAC for FT CHEST CONGEST 400 MG CAPLET has ranged from a low of $0.0644 (Oct 18, 2023) to a high of $0.0744 (Nov 13, 2024), with a median of $0.0682 per EA.

Are there cheaper alternatives to FT CHEST CONGEST 400 MG CAPLET?

Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, HM CHEST CONGEST RLF 400 MG TB, is $0.0661 per EA — about 3% below FT CHEST CONGEST 400 MG CAPLET.

Who manufactures FT CHEST CONGEST 400 MG CAPLET?

FT CHEST CONGEST 400 MG CAPLET (NDC 70677105401) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.